| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 812.646.302 $ | +47.030.426 $ | +16,9 % | 8 | 869.538.976 $ | +147.369.420 $ | +16,7 % | 9 | 748.382.056 $ | +117.505.516 $ | +29,3 % | 8 | ||||
| Edgewise Therapeutics, Inc. | EWTX | → 0 | Stark | 168.525.000 $ | +35.764.750 $ | +26,9 % | 1 | 132.760.250 $ | +45.983.250 $ | +53,0 % | 1 | 86.777.000 $ | +16.638.500 $ | +23,7 % | 1 |
| BROOKFIELD Corp /ON/ | BN | → 0 | 141.493.035 $ | -18.949.648 $ | -11,8 % | 1 | 160.442.683 $ | +594.362 $ | +0,4 % | 1 | 159.848.321 $ | +15.686.485 $ | +10,9 % | 1 | |
| ASML HOLDING NV | ASML | → 0 | Stark | 125.407.525 $ | +3.501.257 $ | +2,9 % | 1 | 121.906.268 $ | -19.276.105 $ | -13,7 % | 1 | 141.182.373 $ | +8.283.061 $ | +6,2 % | 1 |
| Mirum Pharmaceuticals, Inc. | MIRM | → 0 | Neutral | 122.403.500 $ | +22.557.928 $ | +22,6 % | 1 | 99.845.572 $ | +7.179.679 $ | +7,7 % | 1 | 92.665.893 $ | +16.328.094 $ | +21,4 % | 1 |
| Salesforce, Inc. | CRM | → 0 | Neutral | 73.396.217 $ | -14.073.621 $ | -16,1 % | 1 | 87.469.838 $ | +9.215.519 $ | +11,8 % | 1 | 78.254.319 $ | -11.784.374 $ | -13,1 % | 1 |
| Crinetics Pharmaceuticals, Inc. | CRNX | → 0 | Neutral | 56.296.000 $ | -19.347.750 $ | -25,6 % | 1 | 75.643.750 $ | +7.962.500 $ | +11,8 % | 1 | 67.681.250 $ | +23.103.250 $ | +51,8 % | 1 |
| MapLight Therapeutics, Inc. | MPLT | → 0 | Schwach | 74.949.025 $ | +10.193.510 $ | +15,7 % | 1 | 64.755.515 $ | +64.755.515 $ | 1 | |||||
| Viridian Therapeutics, Inc.\DE | VRDN | → 0 | Schwach | 74.065.600 $ | +22.705.200 $ | +44,2 % | 1 | 51.360.400 $ | +18.088.000 $ | +54,4 % | 1 | ||||
| Merus N.V. | → 0 | 70.612.500 $ | +31.162.500 $ | +79,0 % | 1 | ||||||||||
| Zenas BioPharma, Inc. | ZBIO | → 0 | Schwach | 52.649.500 $ | +8.249.500 $ | +18,6 % | 1 | ||||||||
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 50.176.000 $ | +27.384.000 $ | +120,1 % | 1 | ||||||||
| 812.646.302 $ | +47.030.426 $ | +16,9 % | 8 | 869.538.976 $ | +147.369.420 $ | +16,7 % | 9 | 748.382.056 $ | +117.505.516 $ | +29,3 % | 8 | ||||